Document is current
Any future updates will be listed below
-
Authors
-
Clinical Trials BETA
Clinical trials referenced in this document:
nct01376167 at ClinicalTrials.govnct01376167 at ClinicalTrials.govDocuments that mention this clinical trial
Tafenoquine plus chloroquine for the treatment and relapse prevention of Plasmodium vivax malaria (DETECTIVE): a multicentre, double-blind, randomised, phase 2b dose-selection study
https://doi.org/10.1016/s0140-6736(13)62568-4
Relapses of <i>Plasmodium vivax</i> malaria threaten disease elimination: time to deploy tafenoquine in India?
https://doi.org/10.1136/bmjgh-2020-004558
nct02216123 at ClinicalTrials.govDocuments that mention this clinical trial
Tafenoquine plus chloroquine for the treatment and relapse prevention of Plasmodium vivax malaria (DETECTIVE): a multicentre, double-blind, randomised, phase 2b dose-selection study
https://doi.org/10.1016/s0140-6736(13)62568-4
Relapses of <i>Plasmodium vivax</i> malaria threaten disease elimination: time to deploy tafenoquine in India?
https://doi.org/10.1136/bmjgh-2020-004558
Documents that mention this clinical trial
Relapses of <i>Plasmodium vivax</i> malaria threaten disease elimination: time to deploy tafenoquine in India?
https://doi.org/10.1136/bmjgh-2020-004558
- License Information
